Injured by Celebrex Side Effects?
Celebrex is the only COX-2 inhibitor still on the market in the United States. The popular painkiller has been used by millions of Americans and Pfizer is expecting over $2 Billion in sales from the drug Celebrex in 2007 alone.
Celebrex is however linked to serious adverse side effects including heart attacks, strokes and Stevens Johnson Syndrome (SJS).
Update: Schmidt & Clark is no longer accepting Celebrex cases.
What is the Problem?
The Food & Drug Administration in 2005 asked their advisory committee to examine the drug Celebrex to determine whether it offered enough benefits to the consumer stay on the market and whether or not they needed to add stronger warnings to the package inserts. The advisory committee indicated that Celebrex elevates the chances of cardiovascular problems.
Dr. Garret Fitzgerald, a researcher at the University of Pennsylvania, has told the US regulatory panel governing the drug Celebrex that all COX-2 inhibitors increase the risk of heart attacks and strokes. Dr. Fitzgerald has indicated that the body will react the same to Celebrex as it does to Vioxx or Bextra, which have both been removed from the market. Furthermore, Dr. Fitzgerald said that Celebrex creates an imbalance in the body's cardiovascular system that may lead to an increased risk of heart attacks and strokes.
Celebrex Side Effects & Lawsuit News (National)
| NSAIDs Might Lower Breast Cancer Risk - Washington Post THURSDAY, Oct. 9 (HealthDay News) -- Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with a reduced risk for breast cancer, a new review suggests. But the findings aren't an invitation for all women to start popping the popular ... New bill targets rogue druggists on the Internet - Pantagraph WASHINGTON, D.C. -- President Bush is set to sign legislation that will help the federal government crack down on hundreds of rogue Internet pharmacies that peddle controlled substances like the painkiller Vicodin or the stimulant Ritalin. The bill ... October 2008 Mayo Clinic Health Letter Highlights Preventing Alzheimer ... - Forbes ROCHESTER, Minn., Oct. 7 /PRNewswire-USNewswire/ -- Here are highlights from the October issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is ... Subscriber Log In - Wall Street Journal Remember me Forgot your password? President Bush is set to sign legislation that will help the federal government crack down on hundreds of rogue Internet pharmacies that peddle controlled substances like the painkiller Vicodin or the stimulant ... Examine the Pfizer - Market Outlook for a Global Leader, 2008-2013 - Market Wire LONDON, UNITED KINGDOM--(Marketwire - Oct. 6, 2008) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. Pfizer is the world's largest and most profitable pharmaceutical ... Out of joint? Arthritis likely - Orlando Sentinel Question: My joints get very sore when the weather changes. My hips and knees hurt, and I am only 55 years old. Might I have arthritis? Answer: Arthritis affects almost 50 million Americans and is a source of disability for 19 million Americans ... Is the FDA Corrupt? - San Francisco Examiner First of all?who is the FDA? The FDA is an agency within the United States Department of Health and Human Services that is responsible for protecting and promoting the nation's public health. It is organized into several subdivisions that focus on ... DOW Pharmas: Worth A Long Look - Seekingalpha.com The three pharmas in the DJIA are Merck ( MRK ), Pfizer ( PFE ) and Johnson & Johnson ( JNJ ). The three have much in common. For starters, they are the ?evil? drug companies that politicians love to talk about (while pandering to their ... Common Dietary Supplements Don't Help Arthritis - LiveScience.com A graphic shows what's inside your joints, and what can go wrong. Christopher Wanjek is the author of the books "Bad Medicine" and "Food At Work." His Bad Medicine column appears each Tuesday on LiveScience. The natural supplement combo of ... Knee surgery may not be best option - Baltimore Sun The prognosis for people with knee osteoarthritis isn't so bleak as it might seem in the wake of a study finding that arthroscopic surgery, once hailed as promising, may not be the best option. That study, released in the Sept. 11 issue of the New ... |
